Naturally occurring prostaglandin E 2 (PGE 2 ) plays a role in inflammatory responses through eicosanoid signaling pathways. PGE 2 is impermeable to cell membranes at physiological pH and needs solute carrier across the membranes; however, it remains unclear how intercellular concentrations of PGE 2 are regulated under the condition of inflammation. We aimed to clarify a role of organic anion-transporting polypeptide 2A1 (OATP2A1/SLCO2A1), also known as prostaglandin transporter (PGT), in PGE 2 release from cells. Human bronchial epithelial BEAS-2B cells were treated with lipopolysaccharide (LPS), and PGT inhibitors were tested to evaluate contribution of PGT to PGE 2 release by assessing its extracellular concentration and characterizing PGT-mediated PGE 2 efflux in Xenopus laevis oocytes. As a result, LPS elevated mRNA expression of a pro-inflammatory cytokine IL6 and extracellular concentration of PGE 2 in human bronchial epithelial BEAS-2B cells. PGT inhibitors tested (e.g. bromocresol green (BCG), bromosulfophthalein (BSP), and PGB 1 ) significantly inhibited efflux of PGE 2 from oocytes expressing PGT. Similarly, the amount of released PGE 2 from the BEAS-2B cells decreased in the presence of BCG and BSP by 45 and 44% respectively while TGBz increased the concentration by 71%, suggesting that PGT mediates the release. In conclusion, these results imply a role of PGT in regulating intra-and extracellular concentrations of PGE 2 in response to cells under inflammatory conditions.
Introduction
Prostaglandin E 2 (PGE 2 ) plays a major role in eicosanoid signaling pathways, which are well preserved among vertebrates. Naturally occurring PGE 2 exerts diverse physiological actions such as inflammatory responses, uterine contraction, bone resorption, and induction of hyperthermia (Smith 1992) . PGE 2 is synthesized via cyclooxygenase (COX) 1 and 2 from arachidonic acid then transduces diverse physiological actions (Bos et al. 2004) . The downstream events have been studied extensively; however, current evidence is still missing the fundamental basis of how release of PGE 2 is regulated.
Prostaglandins (PGs) including PGE 2 are organic anions with pKa values of around 5 and exist in charged form at physiological pH (Roseman & Yalkowsky 1973) . Hence, PGs are impermeable to cell membranes (Bito & Baroody 1975) and have been suggested not to cross plasma membranes without an aid of transporter systems. There is substantial evidence that organic anion-transporting polypeptides (OATPs) are involved in translocation of PGE 2 across the plasma membranes (Abe et al. 1999 , Tamai et al. 2000 , Kullak-Ublick et al. 2001 . Among those, OATP2A1/SLCO2A1 has been characterized as a solute carrier for PG transporter (PGT), particularly PGE 2 , as it was isolated from adult human kidneys (Lu et al. 1996) . PGT mediates PGE 2 cellular uptake, which can be driven by an exchange of organic anions such as lactate . PGT-mediated PGE 2 uptake from the extracellular environment is an initial step for degradation of PGE 2 by 15-hydroxy PG dehydrogenase (PGDH) in the cytoplasm (Nomura et al. 2004) . Expression of PGT may be coordinately regulated with COXs (Bao et al. 2002) . Furthermore, previous reports have shown that inflammatory effect of stannous chloride, by which heme oxygenase 1 is induced, is attenuated by a resultant elevation of PGE 2 cellular absorption mediated by augmented activity of PGT. Therefore, PGT expression may be associated with inflammatory responses.
On the other hand, several groups have implied that PGT is involved in release of PGE 2 from cells (Chan et al. 1998 , Banu et al. 2003 ; however, contribution of PGT to PGE 2 release from cells remains elusive under physiological conditions. Therefore, we hypothesize that PGT secretes cytoplasmic PGE 2 from cells in response to extracellular inflammatory stimuli, which may accelerate PGE 2 -mediated signaling or enhance inflammatory events in an autocrine manner. Previously, COX and EP receptors have been studied extensively as inflammatory regulators and established as pharmacological targets to control inflammatory reactions. EP receptor antagonists are currently in clinical trials as anti-inflammatory drugs. Compared with those two major factors, limited information is available regarding trans-cellular transport of PGE 2 by PGT. In this study, in order to understand the role of PGT in regulating extracellular concentrations of PGE 2 in response to inflammation, we studied the effect of PGT inhibitors on PGE 2 release and pro-inflammatory cytokine IL6 mRNA expression in human bronchial epithelial cells treated with an inducing agent, lipopolysaccharide (LPS).
Materials and methods
Reagents and antibodies [5, 6, 8, 11, 12, 14, 
Cell culture
Human type 2 pulmonary epithelial A549, airway epithelial Calu-3, and mouse embryonic fibroblast 3T3-L1 cells were obtained from American Type Cell Collection (Manassas, VA, USA), and human bronchial epithelial BEAS-2B cells were purchased from DS Parma Biomedical Co., Ltd. (Osaka, Japan). All cells were grown in DMEM (Life Technology) supplemented with 10% (v/v) fetal bovine serum (Invitrogen, Life Technology), 100 units/ml penicillin, and 100 mg/ml streptomycin, at 37 8C in an atmosphere of 5% CO 2 . BEAS-2B cells were incubated with different concentrations of LPS for 24 h and then mRNA expression of human PGT and IL6 was determined by quantitative real-time RT-PCR.
Enzyme immunoassay for PGE 2 determination
BEAS-2B cells were plated in 60 mm tissue culture plate, and the culture medium was replaced with medium not containing fetal bovine serum when the cells completely attached to the plate. An aliquot of extracellular medium was collected 24 h after LPS was added at the indicated concentration and diluted with enzyme immunoassay (EIA) buffer. The diluted samples were subjected to PGE 2 EIA kit (Cayman Chemicals & Co.) . According to the manufacturer's protocol, PGE 2 concentration was quantified by measuring optical density at 420 nm using a micro-plate reader, ARVO MX (Perkin Elmer Life Science).
Uptake and efflux of PGE 2 from Xenopus laevis oocytes X. laevis oocytes were prepared and injected with in vitro copied RNA (cRNA) of PGT and then subjected to transport assays using radiolabeled PGE 2 . In brief, oocytes were micro-injected with 50 nl of either deionized water or PGT cRNA solution (1 mg/ml) and placed in the oocytes were placed with uptake medium (pH 7.4) containing unlabeled PGE 2 (10 mM) as described previously (Chan et al. 1998 ). Efflux of [ 3 H]PGE 2 was measured for 120 min. For the inhibition study, the assay was performed in the absence (control) or the presence of inhibitor, e.g. BCG, BSP, TGBz, or PGB 1 at the indicated concentrations. The effect of these inhibitors on uptake and efflux was assessed at 60 and 90 min respectively. The kinetic analysis was conducted as described previously (Shirasaka et al. 2010) . 
RT-PCR study

Western blot
To determine protein expression of PGT, cells were lysed in RIPA buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris at pH 8.0) by sonication. A 50 or 100 mg aliquot of the total cell lysate was separated in SDS polyacrylamide gel and then electrotransferred onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA). The blots were probed with anti-human PGT rabbit polyclonal antibody at 1:1000 dilution or with anti-G3PDH rabbit monoclonal antibody (Cell Signaling Technology, Danvers, MA, USA) at 1:2000 dilution, followed by appropriate secondary antibodies conjugated to HRP (Invitrogen, Life Technology). Corresponding expression was detected with electrochemical luminescence assay (Wako).
Immunocytochemistry BEAS-2B cells were plated in eight-well culture slides (BD Falcon, Franklin Lakes, NJ, USA) at a density of 1!10 5 cells/well and then fixed in 4% paraformaldehyde.
Immunostaining was performed by incubating the slides with 1:20 dilution of anti-human PGT rabbit polyclonal antibody for 1 h, followed by staining with 1:400 dilution of AlexaFluor 594-conjugated anti-rabbit IgG (secondary antibody) for 1 h at room temperature. The slides were counterstained with Hoechst 33342 and then mounted with Vectashield (Vector Laboratories Burlingame, CA, USA). Antigenic peptide consisting of amino acids 622-643 of human PGT (CFISWRVKKNKEYNVQKAAGLI) was synthesized in Medical and Biological Laboratories (Nagoya, Japan). The primary antibody to PGT was incubated with the peptide at a molar ratio of 1:100 for 1 h at room temperature and then used to stain cells as a negative control. Fluorescence was examined with a confocal laser microscope LSM710 (Carl Zeiss, Hertfordshire, UK).
PGT knockdown study Sciex, Foster City, CA, USA) coupled with an LC-20AD ultra-fast liquid chromatography system (Shimadzu Co., Kyoto, Japan). The mobile phase composed of the mobile phase at flow rate of 0.2 ml/min. Mercury MS (C18, 20!4.0 mm, Luna 3 mm, Phenomenex, Torrance, CA, USA) was used as the analytical column. Injection volume was 30 ml per sample. Samples were kept at 4 8C during the analysis. The analytes were detected using electrospraynegative ionization and monitoring the mass transitions m/z 351.1/271 for PGE 2 and m/z 355.1/275.2 for d 4 -PGE 2 . Analyst software version 1.4 was used for data manipulation.
Statistical analysis
Data are given as the mean of values obtained in at least three individual experiments with S.E.M. Statistical analyses were performed with the unpaired Student's t-test, and a probability of !0.05 (P!0.05) was considered to be statistically significant.
Results
PGT expression and PGE 2 uptake activity in various cell lines derived from respiratory organ
To determine whether PGT is involved in cellular release of PGE 2 from cells, several cell lines derived from human and rodent respiratory organs were tested for PGT mRNA expression and PGE 2 uptake activity. As summarized in Table 1 , significant mRNA expression of PGT was detected in 3T3-L1 and BEAS-2B cells, as these two cell lines exhibited cellular uptake of PGE 2 at a significant level; therefore, in the following experiments, release of PGE 2 was studied from BEAS-2B cells because it is derived from human bronchial epithelial cells. PGT protein expression in BEAS-2B cells was further studied by means of western blotting and immunocytochemistry. Western blotting showed that three bands between the sizes of 63 and 75 kDa, which were identical to those in HEK293 cells stably transfected with PGT cells, increased in a manner of the loaded amount of cell lysate based on densitometric analysis ( Fig. 1A and B) . Further fluorescence microscopic immunocytochemistry confirmed immunolocalization of PGT in the plasma membranes as well as cytoplasm in BEAS-2B cells because cells stained with pre-absorbed anti-PGT antibody with the synthesized antigenic peptide did not detect such red fluorescence ( Fig. 1C and D) .
Effect of LPS on extracellular PGE 2 concentration and IL6 expression in BEAS-2B cells
Effect of LPS on extracellular PGE 2 concentration and IL6 expression was examined in BEAS-2B cells (Fig. 2) . When the cells were treated with LPS, extracellular concentration of PGE 2 and mRNA expression of IL6 were elevated in a dose-dependent manner of LPS. A somewhat sigmoidal relationship was observed between extracellular concentration of PGE 2 and expression level of IL6 mRNA. When cells were treated with 0.3 mg/ml LPS, extracellular concentration of PGE 2 reached a plateau. Therefore, PGE 2 release was investigated in BEAS-2B cells treated with 0.1 mg/ml LPS in the following experiments. Under this condition, mRNA expression of PGT was lower in LPS-treated BEAS-2B cells than that in the untreated cells, and the expression level was unchanged in another 24 h in the treated cells (Fig. 3A) . When mRNA expression of IL6 was also measured in the same manner, the expression reached the peak at 6 h in the treated cells and the level gradually decreased after 24-h exposure (Fig. 3B) . We further examined the effects of BCG, BSP, TGBz, and PGB 1 , which have been characterized as inhibitors of PGT, on PGE 2 release from BEAS-2B cells for 24 h. Among them, TGBz was reported as an inhibitor with higher affinity to PGT (Ki value of 3.7 mM). As shown in Fig. 4A , BCG (100 mM) and BSP (25 mM) reduced the extracellular concentration of PGE 2 by 45.4 and 44.4% respectively while TGBz (25 mM) and PGB 1 (25 mM) increased the concentration by 71 and 19% respectively. Similar observations were made for the effect of BCG and BSP on IL6 expression in the BEAS-2B cells. IL6 mRNA expression was attenuated in the presence of BCG and BSP by 43.9 and 94.6% respectively. By contrast, TGBz and PGB 1 stimulated IL6 expression by 218 and 342% respectively (Fig. 4B) .
Effects of inhibitors on PGT-mediated PGE 2 transport
Xenopus oocytes injected with PGT cRNA were employed in order to study the effect of these four inhibitors on PGTmediated PGE 2 transport across the plasma membranes. A significant increase in intracellular accumulation of PGE 2 was observed in PGT cRNA-injected oocytes (Fig. 5A ). All the four PGT inhibitors used in this study significantly reduced PGE 2 uptake at 60 min (Fig. 5B) . BCG, BSP, or PGB 1 almost abolished the uptake, while TGBz had the least effect and inhibited as much as 40% of control uptake. Inhibitory potential of these four inhibitors was also verified by their 50% inhibitory concentration (IC 50 ) to PGE 2 uptake, which of BCG, BSP, TGBz, and PGB 1 was estimated as 2.88G0.38, 1.46G0.20, 14.6G2.6, and 0.890G0.086 mM respectively (Fig. 6A, B, C and D) .
In order to determine whether these inhibitors have the same potential for efflux of PGE 2 , first PGT-mediated efflux of PGE 2 was studied in Xenopus oocytes expressing PGT. The released amount of PGE 2 from PGT-expressing oocytes was significantly greater than that from control oocytes (Fig. 7A) . Furthermore, the cis-inhibitory effect on PGT-mediated PGE 2 efflux was examined by injecting labeled PGE 2 with or without inhibitors immediately before the assay and then PGE 2 efflux was measured in the presence of 10 mM PGE 2 in extracellular uptake buffer. BCG (100 mM), BSP (25 mM), and PGB 1 (25 mM) reduced significantly PGT-mediated PGE 2 efflux. TGBz unlikely affected the efflux, although the tested concentration was lower than other inhibitors because of its poor solubility (Fig. 7B) .
Effect of knocking down the PGT mRNA on release of PGE 2 from BEAS-2B cells
To determine whether PGT is involved in PGE 2 release, the PGT gene was knocked down in BEAS-2B cells. In cells transfected with two different siRNA mixtures, PGT mRNA expression was reduced to 30G2% of that of untransfected control cells (Fig. 8A ). As arachidonic acid was added to the medium, the released amount of PGE 2 from the transfected cells for 2 h significantly decreased to 1.05G0.06 ng/well from 1.55G0.07 ng/well for untransfected cells.
Discussion
The intercellular concentration of PGE 2 has to be strictly regulated because PGE 2 is an inflammatory mediator. In this study, we aimed to clarify a role of PGT in PGE 2 release from cells by analyzing PGT-mediated PGE 2 efflux. Airway epithelial cells may function as both target and effector cells in response to external stimuli that cause inflammatory reactions because they can synthesize and release a variety of lipid mediators including PGE 2 , 15-hydroxyeicosatetraenoic acid, PGF 2a , and platelet-activating factor (Churchill et al. 1989 , Salari & Chan-Yeung 1989 . Therefore, we investigated a contribution of PGT to a release of PGE 2 from human bronchial epithelial BEAS-2B cells (Table 1) . Based on the two-step model of PG signals previously reported by Nomura et al., where PGE 2 is first taken up by PGT and then broken down by intracellular PGDH, PGT has been widely accepted as an influx transporter for PGE 2 such that it exerts an antiphlogistic action. By contrast, it remains unclear whether PGT contributes to the release of PGE 2 produced by cells. In this study, we attempted to clarify a role of PGT in PGE 2 secretion under inflammatory conditions. LPS is the microbial product that activates the innate immune system (Ulevitch & Tobias 1995) and upregulates various pro-inflammatory gene expressions including COX2 (PTGS2), CXCL2, IFIT2, CCL2, CCL7, and EDN1 (Aung et al. 2006) . We, therefore, evaluated released PGE 2 from cells treated with LPS and then observed the reduction of extracellular concentration in the presence of BCG or BSP (Fig. 4A ). These two inhibitors were further demonstrated to block the efflux of PGE 2 mediated by PGT when examined in heterologously PGT-expressing Xenopus oocytes (Fig. 7B) . On the other hand, in the presence of TGBz, which exhibited inhibitory effects on uptake but not efflux of PGE 2 , the extracellular concentration of PGE 2 was slightly increased in LPS-treated BEAS-2B cells. More conclusively, a knockdown assay showed a significant contribution of PGT to PGE 2 release from BEAS-2B cells (Fig. 8) . In addition, we learned that PGT protein may not be localized only at the plasma membrane but also in the cytoplasm (Fig. 1C and D) . Because PGT expressed at the plasma membrane is considered to serve as an efflux transporter for PGE 2 , it was hard to judge the alteration in the expression of PGT protein responsible for PGE 2 efflux in siRNA-treated cells by western blotting using their total lysates. In this study, (Endter et al. 2009 ). In addition to MRP4, other solute carriers may also be involved in the release of PGE 2 as previous studies including ours reported that at least OATP1B1 (SLCO1B1), 2B1 (SLCO2B1), 1A2 (SLCO1A2), 3A1 (SLCO3A1), and 4A1 (SLCO4A1) mediate transport of PGE 2 (Tamai et al. 2000 , Kullak-Ublick et al. 2001 , Adachi et al. 2003 and mRNA expression of OATP1A2, 1B3 (SLCO1B3), 3A1, 4A1, and 5A1 (SLCO5A1) was detected in BEAS-2B cells (Endter et al. 2009 ); however, their functional expression may be dependent on the cultural condition because of discrepancies of PGT expression between our study and their report. Hence, our siRNA study at least provides evidence of a significant contribution of PGT to PGE 2 release from BEAS-2B cells, although the contribution of other PGE 2 transporter needs to be clarified in response to LPS stimuli. Another concern is alteration of the mechanism of PGT-mediated transport of PGE 2 . According to previous reports, PGE 2 efflux was stimulated with trans-PGE 2 with a K 1/2 (inhibitory constant) of 290 nM and the effect was saturated at 10 mM when PGT was expressed in Xenopus oocytes (Chan et al. 1998) . According to this report, we analyzed PGE 2 secretion from Xenopus oocytes. In the case of PGE 2 release from the mammalian cells, it has been reported that extracellular lactate stimulates PGTmediated PGE 2 release ; however, the precise mechanism still remains to be determined. As LPS caused a significant release of PGE 2 , we decided not to use PGE 2 as a trans-stimulator for PGT-mediated transport to avoid any physiological effect of PGE 2 on the EP receptor, which may compromise the observed LPS-mediated PGE 2 release. Biological events caused by LPS may optimize or regulate endogenous trans-stimulators as PGE 2 is smoothly secreted. For a further knockdown assay, we employed LC/MS/MS to quantify PGE 2 more consistently and accurately (Fig. 8) . Unfortunately, sensitivity of detection was at most 30-fold decreased; therefore, we had to add arachidonic acid to detect PGE 2 in extracellular medium at a significant level of PGE 2 . In this case, the stimulation effect of LPS was not clearly observed. This could be because PG synthesis induced by arachidonic acid may be much greater than that stimulated by LPS. LPS may alter gene expression of PGT gene expression in BEAS-2B cells. In this study, we observed that LPS (0.1 mg/ml) had only a marginal decrease in PGT mRNA expression in BEAS-2B cells (Fig. 3A) . Limited information is available for the effect of LPS on PGT expression. One report describes that LPS did not affect rat Pgt expression in both mRNA and protein forms in rat cerebral endothelial cells treated with LPS for up to 24 h at the same concentration we used (Tavakoli et al. 2001) . This implies that PGT expression may not be sensitive to LPS stimuli. Comparing LPS-induced reduction of PGT mRNA expression for 48 h with the normal condition, this could be explained as a consequence of damage by LPSinduced production of pro-inflammatory cytokines; however, this should be addressed by future studies.
LPS is a component of the Gram-negative bacterial cell membrane and has been suggested to mediate inflammation via CD14/TLR4/MD2 receptor complexes. LPS signal is transduced through MAP kinase pathways and activates various transcription factors, resulting in induction of genes encoding pro-inflammatory cytokines, e.g. IL6 and TNF-a. Independently, it is reported that BEAS-2B cells express EP 1 , EP 2 , and EP 4 receptors, and their exposure to PGE 2 increases IL6 mRNA expression (Tavakoli et al. 2001) . Interestingly, the effect of three PGT inhibitors (e.g. BCG, BSP, and TGBz) on PGT-mediated release (Fig. 7B ) similarly corresponded to their effect on IL6 mRNA expression in LPS-treated BEAS-2B cells (Fig. 4B) . On the other hand, as shown in Figs 5B, 6D, and 7B, despite the inhibitory effect of PGB 1 on PGT-mediated PGE 2 uptake, PGB 1 elevated extracellular PGE 2 concentration and IL6 mRNA expression in LPS-treated BEAS-2B cells. This inconsistency may be possibly explained by several mechanisms; for instance, PGB 1 may act directly on EP receptors as their agonist or antagonist, or extracellular PGB 1 may not exert an inhibition of PGT-mediated release. These results suggest that extracellular PGE 2 , which may be adjustable by PGT, regulates signal through the EP receptor in an autocrine model. Accordingly, modulation of PGT-mediated release may provide an antiphlogistic benefit if further study defines such a role of PGT under inflammatory conditions.
In conclusion, our study implies a critical role of PGT in regulating the extracellular concentration of PGE 2 by controlling its trans-cellular transport across the plasma membranes in cells under inflammatory conditions. Further studies should be warranted to clarify a transporter responsible for PGE 2 and its alteration in gene expression and intracellular localization under inflammatory conditions. Better understanding of a precise mechanism that determines PGT-mediated PGE 2 transport may provide a new rationale to efficiently control inflammatory responses induced by extracellular signaling.
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